Diagnostic and Biotech

2015-2019 US Cancer Diagnostics Industry: Market Segmentation Analysis-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Hospitals, Commercial Labs, POC Locations

  • VPG323111
  • 620 Pages
  • August 2015
  • Diagnostic and Biotech

Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.


2015-2019 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations is VPGMarketResearchs new study of the major business opportunities emerging in the US cancer diagnostics market during the nextfive years. The report examines trends in the US market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.


US Market Overview


- Five-year test volume and sales projections.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of laboratories performing cancer diagnostic testing.


- Cancer statistics, etiology and recent developments in the US.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test.


- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:


Hospitals

Commercial/Private Laboratories

Physician Offices/Group Practices

Cancer Clinics

Ambulatory Care Centers


Instrumentation Review


- Analysis of major molecular diagnostic and immunodiagnostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies.


- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative cancer diagnostic

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- AdnaGen

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode Genetics

- Diadexus

- Diagnocure

- DiaSorin

- Eiken Chemical

- Elitech Group

- Epigenomics

- Enterix

- Enzo Biochem

- Exact Sciences

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- OncoLab

- Ortho-Clinical Diagnostics

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zilla


Contains 620 pages and 103 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Protein Purification and Isolation Market - Opportunities and Forecasts, 2015 - 2020

Protein purification is the process of isolating proteins from the complex mixtures of cells, tissues, or organisms based on differences in their physical properties. The protein purification process aims to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Next Generation Sequencers Market (Applications, Technology, Requirements for processing, End-Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Forensic Technologies Market (Service, Products and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Forensic technology is used for identification, interpretation and assessment of substantial evidences gathered from site of crime. Forensic science has witnessed tremendous developments in its technologies which in turn have ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

2017 © Copyright Big Market Research

View Pricing >>